<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9882624" created="23/05/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9882624</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Mildly <term id="A12" sem="Protein_family_or_group">oxidized <term id="T1" lex="low-density_lipoprotein" sem="Protein_family_or_group">low-density lipoproteins</term></term> decrease early production of <term id="T2" lex="interleukin_2" sem="Protein_molecule">interleukin 2</term> and <term id="T3" lex="nuclear_factor_kappaB" sem="Protein_complex">nuclear factor kappaB</term> binding to <term id="A1" sem="DNA_domain_or_region">DNA</term> in <term id="T4" lex="activated_T-lymphocyte" sem="Cell_natural">activated <term id="A2" sem="Cell_natural">T-lymphocytes</term></term>.</sentence>
<event id="E1">
<type class="Negative_regulation"/>
<theme idref="E3"/>
<cause idref="A12"/>
<clue>Mildly oxidized low-density lipoproteins <clueType>decrease</clueType> early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E4"/>
<cause idref="A12"/>
<clue>Mildly oxidized low-density lipoproteins <clueType>decrease</clueType> early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.</clue>
</event>
<event id="E3">
<type class="Gene_expression"/>
<theme idref="T2"/>
<clue>Mildly oxidized low-density lipoproteins decrease <clueTime>early</clueTime> <clueType>production</clueType> <linkTheme>of</linkTheme> interleukin 2 and nuclear factor kappaB binding to DNA <clueLoc>in activated T-lymphocytes</clueLoc>.</clue>
</event>
<event id="E4">
<type class="Binding"/>
<theme idref="T3"/>
<theme idref="A1"/>
<clue>Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB <clueType>binding</clueType> <linkTheme>to</linkTheme> DNA <clueLoc>in activated T-lymphocytes</clueLoc>.</clue>
</event>
<event id="E5">
<type class="Physiological_process"/>
<theme idref="A2"/>
<clue>Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in <clueType>activated</clueType> T-lymphocytes.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Activated <term id="A3" sem="Cell_natural">T-lymphocytes</term> are found early in <term id="T5" lex="atherosclerosis_lesion" sem="Tissue_natural">atherosclerosis lesions</term>, but little is known about their role.</sentence>
<event KT="Other" id="E6">
<type class="Physiological_process"/>
<theme idref="A3"/>
<clue><clueType>Activated</clueType> T-lymphocytes are found <clueTime>early</clueTime> <clueLoc>in atherosclerosis lesions</clueLoc>, but little is known about their role.</clue>
</event>
<sentence id="S3">Oxidized <term id="T6" lex="low-density_lipoprotein" sem="Protein_family_or_group">low-density lipoproteins</term> (<term id="T7" lex="oxLDL" sem="Protein_family_or_group">oxLDLs</term>) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that <term id="T8" lex="oxLDL" sem="Protein_family_or_group">oxLDLs</term> inhibit not only <term id="T9" lex="interleukin_(IL)-2-receptor_expression" sem="Other"><term id="T10" lex="interleukin_(IL)-2-receptor" sem="Protein_molecule">interleukin (IL)-2-receptor</term> expression</term> on the surface of in vitro-<term id="A13" sem="Cell_natural">activated <term id="A4" sem="Cell_natural">T-lymphocytes</term></term> but also their proliferation.</sentence>
<event CL="L2" KT="Analysis" id="E7">
<type class="Regulation"/>
<theme idref="E40"/>
<cause idref="T7"/>
<clue>Oxidized low-density lipoproteins (oxLDLs) are <clueKT><clueCL>considered to be</clueCL></clueKT> <clueType>involved</clueType> <linkTheme>in</linkTheme> the pathogenesis of the lesions, and we have previously demonstrated that oxLDLs inhibit not only interleukin (IL)-2-receptor expression on the surface of in vitro-activated T-lymphocytes but also their proliferation.</clue>
</event>
<event KT="Other" id="E40">
<type/>
<theme idref="T5"/>
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the <clueType>pathogenesis</clueType> <linkTheme>of</linkTheme> <corefTheme>the lesions</corefTheme>, and we have previously demonstrated that oxLDLs inhibit not only interleukin (IL)-2-receptor expression on the surface of in vitro-activated T-lymphocytes but also their proliferation.</clue>
<comment>SOO</comment></event>
<event KT="Analysis" id="E8">
<type class="Negative_regulation"/>
<theme idref="E10"/>
<cause idref="T8"/>
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the pathogenesis of the lesions, and we have <clueSource>previously</clueSource> <clueKT>demonstrated</clueKT> that oxLDLs <clueType>inhibit</clueType> not only interleukin (IL)-2-receptor expression on the surface of in vitro-activated T-lymphocytes but also their proliferation.</clue>
</event>
<event KT="Analysis" id="E9">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="T8"/>
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the pathogenesis of the lesions, and we have <clueSource>previously</clueSource> <clueKT>demonstrated</clueKT> that oxLDLs <clueType>inhibit</clueType> not only interleukin (IL)-2-receptor expression on the surface of in vitro-activated T-lymphocytes but also their proliferation.</clue>
</event>
<event KT="Other" id="E10">
<type class="Gene_expression"/>
<theme idref="T10"/>
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that oxLDLs inhibit not only interleukin (IL)-2-receptor <clueType>expression</clueType> <clueLoc>on the surface of in vitro-activated T-lymphocytes</clueLoc> but also their proliferation.</clue>
</event>
<event KT="Other" id="E11">
<type class="Cellular_physiological_process"/>
<theme idref="A13"/>
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that oxLDLs inhibit not only interleukin (IL)-2-receptor expression on the surface of in vitro-activated T-lymphocytes but also <corefTheme>their</corefTheme> <clueType>proliferation</clueType>.</clue>
</event>
<event KT="Other" id="E12">
<type class="Physiological_process"/>
<theme idref="A4"/>
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that oxLDLs inhibit not only interleukin (IL)-2-receptor expression on the surface of in vitro-<clueType>activated</clueType> T-lymphocytes but also their proliferation.</clue>
</event>
<sentence id="S4">We have now investigated the effect of <term id="T11" lex="oxLDL" sem="Protein_family_or_group">oxLDLs</term> on <term id="T12" lex="blast_differentiation" sem="Other">blast differentiation</term>, on <term id="T13" lex="IL-2_synthesis" sem="Other"><term id="T14" lex="IL-2" sem="Protein_molecule">IL-2</term> synthesis</term> and on the activation of the <term id="T15" lex="nuclear_factor_kappaB_(NF-kappaB)_system" sem="Other"><term id="T16" lex="nuclear_factor_kappaB" sem="Protein_complex">nuclear factor kappaB</term> (<term id="T17" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>) system</term> in activated <term id="A5" sem="Cell_natural">lymphocytes</term>.</sentence>
<event KT="Investigation" id="E13" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T12"/>
<cause idref="T11"/>
<clue>We have now <clueKT>investigated</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> oxLDLs <linkTheme>on</linkTheme> blast differentiation, on IL-2 synthesis and on the activation of the nuclear factor kappaB (NF-kappaB) system <clueLoc>in activated lymphocytes</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E14" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E16"/>
<cause idref="T11"/>
<clue>We have now <clueKT>investigated</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> oxLDLs on blast differentiation, <linkTheme>on</linkTheme> IL-2 synthesis and on the activation of the nuclear factor kappaB (NF-kappaB) system in activated lymphocytes.</clue>
</event>
<event KT="Investigation" id="E15" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E17"/>
<cause idref="T11"/>
<clue>We have now <clueKT>investigated</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> oxLDLs on blast differentiation, on IL-2 synthesis and <linkTheme>on</linkTheme> the activation of the nuclear factor kappaB (NF-kappaB) system in activated lymphocytes.</clue>
</event>
<event KT="Other" id="E16">
<type class="Gene_expression"/>
<theme idref="T14"/>
<clue>We have now investigated the effect of oxLDLs on blast differentiation, on IL-2 <clueType>synthesis</clueType> and on the activation of the nuclear factor kappaB (NF-kappaB) system <clueLoc>in activated lymphocytes</clueLoc>.</clue>
</event>
<event KT="Other" id="E17">
<type class="Positive_regulation"/>
<theme idref="T17"/>
<clue>We have now investigated the effect of oxLDLs on blast differentiation, on IL-2 synthesis and on the <clueType>activation</clueType> <linkTheme>of</linkTheme> the nuclear factor kappaB (NF-kappaB) system <clueLoc>in activated lymphocytes</clueLoc>.</clue>
</event>
<event KT="Other" id="E18">
<type class="Physiological_process"/>
<theme idref="A5"/>
<clue>We have now investigated the effect of oxLDLs on blast differentiation, on IL-2 synthesis and on the activation of the nuclear factor kappaB (NF-kappaB) system in <clueType>activated</clueType> lymphocytes.</clue>
</event>
<sentence id="S5">Mildly <term id="T18" lex="oxLDL" sem="Protein_family_or_group">oxLDLs</term> (50 and 100 microgram/ml) decreased the number of <term id="T19" lex="lymphoblast" sem="Cell_natural">lymphoblasts</term> and the level of <term id="A6" sem="Protein_molecule">IL-2</term> concentration in the culture supernatants after activation of <term id="T20" lex="lymphocyte" sem="Cell_natural">lymphocytes</term> by <term id="T21" lex="phytohaemagglutinin" sem="Protein_molecule">phytohaemagglutinin</term> and <term id="T22" lex="PMA+ionomycin" sem="Organic_compound_other"><term id="A7" sem="Organic_compound_other">PMA</term>+<term id="T23" lex="ionomycin" sem="Organic_compound_other">ionomycin</term></term>.</sentence>
<event id="E19">
<type class="Negative_regulation"/>
<theme idref="T19"/>
<cause idref="T18"/>
<clue>Mildly oxLDLs (50 and 100 microgram/ml) <clueType>decreased</clueType> the number <linkTheme>of</linkTheme> lymphoblasts and the level of IL-2 concentration in the culture supernatants after activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin.</clue>
</event>
<event id="E20">
<type class="Negative_regulation"/>
<theme idref="A6"/>
<cause idref="T18"/>
<clue>Mildly oxLDLs (50 and 100 microgram/ml) <clueType>decreased</clueType> the number of lymphoblasts and the level <linkTheme>of</linkTheme> IL-2 concentration <clueLoc>in the culture supernatants</clueLoc> after activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin.</clue>
</event>
<event id="E21">
<type class="Physiological_process"/>
<theme idref="T20"/>
<cause idref="T21"/>
<clue>Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants after <clueType>activation</clueType> <linkTheme>of</linkTheme> lymphocytes <linkCause>by</linkCause> phytohaemagglutinin and PMA+ionomycin.</clue>
</event>
<event id="E22">
<type class="Physiological_process"/>
<theme idref="T20"/>
<cause idref="A7"/>
<cause idref="T23"/>
<clue>Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants after <clueType>activation</clueType> <linkTheme>of</linkTheme> lymphocytes <linkCause>by</linkCause> phytohaemagglutinin and PMA+ionomycin.</clue>
</event>
<event id="E23">
<type class="Regulation"/>
<theme idref="E19"/>
<cause idref="E21"/>
<clue>Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants <linkCause>after</linkCause> activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E24">
<type class="Regulation"/>
<theme idref="E20"/>
<cause idref="E21"/>
<clue>Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants <linkCause>after</linkCause> activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E25">
<type class="Regulation"/>
<theme idref="E19"/>
<cause idref="E22"/>
<clue>Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants <linkCause>after</linkCause> activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E26">
<type class="Regulation"/>
<theme idref="E20"/>
<cause idref="E22"/>
<clue>Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants <linkCause>after</linkCause> activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S6">The inhibition of <term id="T24" lex="IL-2" sem="Protein_molecule">IL-2</term> production was observed in the <term id="T25" lex="CD3(+)_T-lymphocyte_cytoplasm" sem="Cell_component"><term id="T26" lex="CD3" sem="Protein_molecule">CD3</term>(+) <term id="A8" sem="Cell_natural">T-lymphocyte</term> cytoplasm</term> as early as 4 h after activation by <term id="T27" lex="PMA+ionomycin" sem="Organic_compound_other"><term id="A9" sem="Organic_compound_other">PMA</term>+<term id="T28" lex="ionomycin" sem="Organic_compound_other">ionomycin</term></term>.</sentence>
<event id="E27">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<cause idref="E29"/>
<clue>The <clueType>inhibition</clueType> <linkTheme>of</linkTheme> IL-2 production was <clueKT>observed</clueKT> <clueLoc>in the CD3(+) T-lymphocyte cytoplasm</clueLoc> <clueTime>as early as 4 h</clueTime> <linkCause>after</linkCause> activation by PMA+ionomycin.</clue>
</event>
<event KT="Other" id="E28">
<type class="Gene_expression"/>
<theme idref="T24"/>
<clue>The inhibition of IL-2 <clueType>production</clueType> was observed in the CD3(+) T-lymphocyte cytoplasm as early as 4 h after activation by PMA+ionomycin.</clue>
</event>
<event id="E29">
<type class="Physiological_process"/>
<theme idref="A8"/>
<cause idref="A9"/>
<cause idref="T28"/>
<clue>The inhibition of IL-2 production was observed in the CD3(+) T-lymphocyte cytoplasm as early as 4 h after <clueType>activation</clueType> <linkCause>by</linkCause> PMA+ionomycin.</clue>
</event>
<sentence id="S7">The study of <term id="T29" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> showed that <term id="T30" lex="oxLDL" sem="Protein_family_or_group">oxLDLs</term> led to a decrease of activation-induced <term id="A14" sem="Protein_complex"><term id="A10" sem="Protein_molecule">p65</term>/<term id="T32" lex="p50" sem="Protein_molecule">p50</term> <term id="T33" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> heterodimer</term> binding to <term id="A11" sem="DNA_domain_or_region">DNA</term>, whereas the presence of the constitutive nuclear form of <term id="T34" lex="p50_dimer" sem="Protein_complex"><term id="T35" lex="p50" sem="Protein_molecule">p50</term> dimer</term> was unchanged.</sentence>
<event KT="Analysis" id="E31">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="T30"/>
<clue>The study of NF-kappaB <clueKT>showed</clueKT> that oxLDLs led to a <clueType>decrease</clueType> <linkTheme>of</linkTheme> activation-induced p65/p50 NF-kappaB heterodimer binding to DNA, whereas the presence of the constitutive nuclear form of p50 dimer was unchanged.</clue>
</event>
<event KT="Other" id="E32">
<type class="Binding"/>
<theme idref="A14"/>
<theme idref="A11"/>
<clue>The study of NF-kappaB showed that oxLDLs led to a decrease of activation-induced p65/p50 NF-kappaB heterodimer <clueType>binding</clueType> <linkTheme>to</linkTheme> DNA, whereas the presence of the constitutive nuclear form of p50 dimer was unchanged.</clue>
</event>
<event KT="Other" id="E34">
<type class="Positive_regulation"/>
<theme idref="E32"/>
<cause idref="E29"/>
<clue>The study of NF-kappaB showed that oxLDLs led to a decrease of <corefCause>activation</corefCause>-<clueType>induced</clueType> p65/p50 NF-kappaB heterodimer binding to DNA, whereas the presence of the constitutive nuclear form of p50 dimer was unchanged.</clue>
<comment>NER: T31 del &quot;activation-induced p65/ p50&quot;</comment></event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E35">
<type class="Negative_regulation"/>
<theme idref="T34"/>
<clue>The study of NF-kappaB <clueKT>showed</clueKT> that oxLDLs led to a decrease of activation-induced p65/p50 NF-kappaB heterodimer binding to DNA, whereas the presence of the constitutive <clueLoc>nuclear</clueLoc> form of p50 dimer was <clueType><cluePolarity>unchanged</cluePolarity></clueType>.</clue>
</event>
<sentence id="S8">This was correlated with an unchanged level of the active form of the <term id="T36" lex="cytosolic_inhibitor_protein" sem="Protein_family_or_group">cytosolic inhibitor protein</term> <term id="T37" lex="IkappaB-alpha" sem="Protein_molecule">IkappaB-alpha</term>.</sentence>
<event KT="Analysis" id="E36">
<type class="Correlation"/>
<theme idref="E35"/>
<theme idref="T37"/>
<clue><corefTheme>This</corefTheme> was <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> an unchanged level of the active form of the <clueLoc>cytosolic</clueLoc> inhibitor protein IkappaB-alpha.</clue>
</event>
<sentence id="S9">Taken together, these observations suggest that the immunosuppressive effect of <term id="T38" lex="oxLDL" sem="Protein_family_or_group">oxLDLs</term> might operate via a <term id="T39" lex="dysregulation" sem="Other">dysregulation</term> of the <term id="T40" lex="T-lymphocyte_activation_mechanisms" sem="Other"><term id="T41" lex="T-lymphocyte" sem="Cell_natural">T-lymphocyte</term> activation mechanisms</term>.</sentence>
<event KT="Other" id="E37">
<type class="Negative_regulation"/>
<cause idref="T38"/>
<clue>Taken together, these observations suggest that the <clueType>immunosuppressive effect</clueType> <linkCause>of</linkCause> oxLDLs might operate via a dysregulation of the T-lymphocyte activation mechanisms.</clue>
<comment>NO THEME</comment></event>
<event CL="L1" KT="Analysis" id="E38">
<type class="Positive_regulation"/>
<theme idref="E39"/>
<cause idref="E37"/>
<clue>Taken together, these observations <clueKT>suggest</clueKT> that the immunosuppressive effect of oxLDLs <clueType><clueCL>might</clueCL> operate</clueType> <linkCause>via</linkCause> a dysregulation of the T-lymphocyte activation mechanisms.</clue>
</event>
<event KT="Other" id="E39">
<type class="Regulation"/>
<theme idref="T40"/>
<clue>Taken together, these observations suggest that the immunosuppressive effect of oxLDLs might operate via a <clueType>dysregulation</clueType> <linkTheme>of</linkTheme> the T-lymphocyte activation mechanisms.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
